The finding published in PLoS One suggests that elevated oxidized LDL cholesterol and fructosamine – a measure of glycated proteins in blood sugar – are signposts for the development of severe coronary disease, especially in females.
UNC’s Heart Health Now! Advancing Heart Health in NC Primary Care project is one of seven grantees awarded as part of the AHRQ initiative, EvidenceNOW – Advancing Heart Health in Primary Care.
The findings could lead to more personalized approaches to controlling platelet activity during heart attacks and other vascular emergencies and diseases. Wolfgang Bergmeier, PhD, professor of biochemistry and biophysics, member of the McAllister Heart Institute at UNC, is senior author of the paper.
By bumping up the levels of a well-known protein in the heart, UNC researchers have found a new way to generate more blood vessels following a heart attack.
Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke.
UNC’s William Powers, MD, provides the first hard evidence for how to treat stroke patients with poor collateral blood vessel formation.
The UNC Center for Heart and Vascular Care collaborates with specialists in the Raleigh area to provide care for the most complex heart cases. (This feature was originally published in UNC Health Care's Well Magazine, Winter 2014 issue)
A North Carolina nonprofit organization and a UNC Hospitals volunteer partnered to bring an 8-year-old girl with congenital heart problems to UNC for medical treatment.
A new study by UNC researchers finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital.
On Monday, June 18, 2012, the UNC Center for Heart & Vascular Care’s Aortic Disease Management team became the first in the U.S. to successfully treat a complex abdominal aortic aneurysm (AAA) with the Zenith® Fenestrated AAA Endovascular Graft.
Cardiology, Heart Health, Innovation, Technology, Treatment, Vascular Health
A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to the formation of abnormal blood clots. They turned it off using a popular class of cholesterol-lowering drugs, statins.
Cardiology, Innovation, Research, Studies, Treatment, Vascular Health
